PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-811

  1. 120 Posts.
    lightbulb Created with Sketch. 10
    No statistically significant p value, no viable, tested dose, no partnering or additional funding=no phase 3.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.